Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2001 Mar 13;14(6):284–292. doi: 10.1002/1098-2825(20001212)14:6<284::AID-JCLA7>3.0.CO;2-U

Reference distributions for the positive acute phase serum proteins, α1‐acid glycoprotein (orosomucoid), α1‐antitrypsin, and haptoglobin: A practical, simple, and clinically relevant approach in a large cohort

Robert F Ritchie 1,✉, Glenn E Palomaki 1, Louis M Neveux 1, Olga Navolotskaia 1, Thomas B Ledue 1, Wendy Y Craig 1
PMCID: PMC6807811  PMID: 11138611

Abstract

Most clinical conditions are accompanied by corresponding changes in serum levels of some, if not all, of the acute phase proteins. While conditions that affect the acute phase proteins are usually inflammatory in nature, non‐inflammatory conditions also can cause changes (e.g., malnutrition, some malignancies without secondary inflammation, and genetic polymorphism). Only after the confounding effects of non‐inflammatory conditions are taken into account can these measurements be used to detect and stage the inflammatory process and to evaluate the impact of treatment. In this third article in a series, reference ranges for serum levels for three of the acute phase proteins that increase during inflammation are examined: α1‐acid glycoprotein (orosomucoid), α1‐antitrypsin, and haptoglobin. The study is based on a cohort of 55,199 Caucasian individuals from northern New England, tested in our laboratory between 1994 and 1999. Measurements were standardized against CRM 470 (RPPHS) and analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C‐reactive protein of 10 mg/l or higher) were excluded. Levels of α1‐acid glycoprotein changed little during life and between the sexes. Levels of α1‐antitrypsin varied somewhat by age, rising slightly beyond age 55; males followed a pattern similar to that for females. For this protein, it was necessary to apply two equations to describe the lower levels associated with certain phenotypes. Haptoglobin levels fell significantly during the first decade of life for both males and females and climbed thereafter. Males and females displayed a similar pattern. When values were expressed as multiples of the age‐ and gender‐specific median levels, the resulting distributions fitted a log–Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual’s measurement, thus simplifying interpretation. J. Clin. Lab. Anal. 14:284–292, 2000. © 2000 Wiley‐Liss, Inc.

Keywords: acute phase proteins, reference range, reference material, Caucasian, α1‐acid glycoprotein, α1‐antitrypsin, haptoglobin, orosomucoid

Contributor Information

Robert F. Ritchie, Email: ritchie@fbr.org.

Glenn E. Palomaki, Email: palomaki@fbr.org

REFERENCES

  • 1. Whicher JT, Ritchie RF, Johnson AM, et al. 1994. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 40:934–938. [PubMed] [Google Scholar]
  • 2. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. 1999. Reference distributions for the negative acute phase proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Lab Clin Anal 13:273–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. 1998. Reference distributions for immunoglobulins A, G and M: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 12:363–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Hudson GA, Poulin SE, Ritchie RF. 1987. Twelve‐protein immunoassay profile on the COBAS FARA. J Clin Lab Anal 1:191–197. [Google Scholar]
  • 5. Healy MJR. 1979. Outliers in clinical chemistry quality‐control schemes. Clin Chem 25:675–677. [PubMed] [Google Scholar]
  • 6. Dixon WJ. 1992. Monte Carlo Simulation. Los Angeles; BMDP Statistical Software, Inc. p. 645–646.
  • 7. Haram K, Augensen K, Elsayed S. 1983. Serum protein in normal pregnancy with special reference to acute‐phase reactants. Br J Obstet Gynaecol 90:139–145. [DOI] [PubMed] [Google Scholar]
  • 8. Giacoia GP. 1984. Concentration of serum prealbumin and retinol‐binding proteins during pregnancy. South Med J 77:1261–1263. [DOI] [PubMed] [Google Scholar]
  • 9. Jeppsson J‐A. 1996. 1‐Antitrypsin. In: Ritchie RF, Navolotskaia O, editors. Serum Proteins in Clinical Medicine, Vol. I, Laboratory Section. Scarborough, ME: Foundation for Blood Research. p 10.1.1–10.1.7.
  • 10. Jeppsson J‐A. 1999. Chronic obstructive pulmonary disease. In: Ritchie RF, Navolotskaia O, editors. Serum Proteins in Clinical Medicine, Vol. II, Clinical Section. Scarborough, ME: Foundation for Blood Research. p 110.0.1–110.0.10.
  • 11. Song CS, Merkatz IR, Rifking AB, Gillette PN, Kappas A. 1970. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Am J Obstet Gynecol 108:227–231. [DOI] [PubMed] [Google Scholar]
  • 12. Dotchev D, Liappis N, Hingerland H. 1973. Sex‐specific differences of serum proteins in adults and influence of oral hormonal contraceptives on serum protein compositions. Clin Chim Acta 44:431–435. [DOI] [PubMed] [Google Scholar]
  • 13. Navolotskaia O. 1999. Pregnancy/hormone effect. Serum Proteins in Clinical Medicine, Vol. II, Clinical Section. Scarborough, ME: Foundation for Blood Research. p 106.0.1–106.0.11.
  • 14. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979. [DOI] [PubMed] [Google Scholar]
  • 15. Joyce PR, Hawes CR, Mulder RT, Sellmen JD, Wilson DA, Boswell DR. 1992. Elevated levels of acute phase proteins in major depression. Biol Psychiatry 32:1035–1041. [DOI] [PubMed] [Google Scholar]
  • 16. Thompson DK, Haddow JE, Smith DE, Ritchie RF. 1981. Serum protein changes in women with early breast cancer. Cancer 48:793–798. [DOI] [PubMed] [Google Scholar]
  • 17. Maes M, Wauters A, Neels H, et al. 1995. Total serum protein and serum protein fractions in depression: relationship to depressive symptoms and glucocorticoid activity. J Affective Disord 34:61–69. [DOI] [PubMed] [Google Scholar]
  • 18. Ledue TB, Johnson MJ, Cohen LA, Ritchie RF. 1998. Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem 44:878–879. [PubMed] [Google Scholar]
  • 19. Jilma B, Diringer E, Löscher I, et al. 1997. Menstrual cycle‐associated changes in blood levels of interleukin‐6, α1‐acid glycoprotein, and C‐reactive protein. J Lab Clin Med 130:69–75. [DOI] [PubMed] [Google Scholar]
  • 20. Chatard JC, Mujika I, Guy C, Lacour JR. 1999. Anaemia and iron deficiency in athletes. Practical recommendations for treatment. Sports Med 27:229–240. [DOI] [PubMed] [Google Scholar]
  • 21. Valette I, Pointis J, Rondeau Y, Waks M, Engler R. 1979. Is immunochemical determination of haptoglobin phenotype dependent? Clin Chim Acta 99:1–6. [DOI] [PubMed] [Google Scholar]
  • 22. Van Rijn HJM, Van Der Wilt W, Stroes JW, Schrijver J. 1987. Is the turbidimetric immunoassay of haptoglobin phenotype‐dependent? Clin Biochem 20:245–248. [DOI] [PubMed] [Google Scholar]
  • 23. Schrijver J, Van Rijn HJM, Schreurs WHP. 1984. Re‐evaluation of the haptoglobin reference values with the radial immunodiffusion technique. Clin Biochem 17:258–262. [DOI] [PubMed] [Google Scholar]
  • 24. Ingelbleek Y, Young V. 1994. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 14:495–533. [DOI] [PubMed] [Google Scholar]
  • 25. Larsen PR. 1972. Salicylate‐induced increases in free triiodothyronine in human serum. Evidence of inhibition of triiodothyronine binding to thyroxine‐binding prealbumin. J Clin Invest 52:1125–1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. National Committee for Clinical Laboratory Standards . 1995. How to Define and Determine Reference Intervals in the Clinical Laboratory. Approved Guideline. NCCLS Document C28‐A. 771 East Lancaster Avenue, Villanova, PA 19085:NCCLS.
  • 27. Gräsbeck R, Siest G, Wilding P, Williams GZ, Whitehead TP. 1978. Provisional recommendation on the theory of reference values. Part 1. The concept of reference values. Clin Chim Acta 87:461F–465F. [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES